Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7.
Shujie ChenTingting SuYing ZhangAllen LeeJiamin HeQi-Wei GeLan WangJianmin SiWei ZhuoLiang-Jing WangPublished in: Gut microbes (2020)
The enrichment of Fusobacterium nucleatum (Fn) has been identified in CRC patients and associated with worse outcomes. However, whether Fn was involved in the metastasis of CRC was not well determined. Here, we found that the abundance of Fn was significantly increased in CRC patients with lymph nodes metastasis. To further clarify the role of Fn in CRC metastasis, we performed transwell and wound healing assays after incubating CRC cell lines with or without Fn and injected Fn-treated or untreated CRC cells into nude mice via tail vein. The results indicated that Fn infection promoted CRC cells migration in vitro, as well as lung metastasis in vivo. Interestingly, colonization of Fn was detected in metastatic lung lesions of nude mice by fluorescence in situ hybridization. Mechanistically, RNA sequencing and validation study revealed that Fn significantly upregulated the expression of long non-coding RNA Keratin7-antisense (KRT7-AS) and Keratin7 (KRT7) in CRC cells. Importantly, Fn-induced CRC lung metastasis was attenuated by the depletion of KRT7-AS. In addition, KRT7-AS facilitated CRC cells migration by upregulating KRT7. Subsequently, we found that NF-κB signaling pathway was involved in the upregulation of KRT7-AS upon Fn infection. In conclusion, Fn infection upregulated KRT7-AS/KRT7 by activating NF-κB pathway, which promoted CRC cell migration in vitro and metastasis in vivo.
Keyphrases
- signaling pathway
- induced apoptosis
- long non coding rna
- cell cycle arrest
- pi k akt
- poor prognosis
- oxidative stress
- squamous cell carcinoma
- lymph node
- endoplasmic reticulum stress
- small cell lung cancer
- newly diagnosed
- immune response
- type diabetes
- high throughput
- end stage renal disease
- cell proliferation
- early stage
- ejection fraction
- nuclear factor
- patient reported outcomes
- prognostic factors
- cell death
- skeletal muscle
- insulin resistance
- peritoneal dialysis
- endothelial cells
- weight loss
- toll like receptor
- neoadjuvant chemotherapy